Laura Kreutzer

Plus: Fortress-Backed Brightline is preparing a bankruptcy filing and J.P. Morgan considers opening credit card door for private-credit firms.

Plus: Fortress-Backed Brightline is preparing a bankruptcy filing and J.P. Morgan considers opening credit card door for private-credit firms.

Plus, Crosspoint doubles down on AI security, Leon Black is held in contempt and Silversmith invests in Vantora.

Plus, PE-backed EverBank agrees to a reverse merger and investors rediscover love for backing companies that focus on live experiences.

Its Graphyte platform aims to help banks and other organizations ferret out money-laundering and other financial crime, the company says.

The firm reached the upper limits for two new funds despite investor concern about potential AI disruptions of the software sector.

The initial closings of the firm’s Asset Opportunity Fund III and a parallel fund focused on insurance exceed the size of an $825 million predecessor in 2021.

Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about $1.075 billion.

The recently formed private-equity firm focused on healthcare is acquiring WIN from NexPhase Capital.

Executives who manage family wealth advised against following the investor herd during a recent conference in Zurich.